EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study

Joshua P Entrop iD, Caroline E Weibull iD, Karin E Smedby, Lasse H Jakobsen, Andreas K Øvlisen iD, Daniel Molin, Ingrid Glimelius iD, Anna Marklund iD, Harald Holte iD, Alexander Fosså iD, Knut B Smeland iD, Tarec C El-Galaly iD und 1 weitere

International Journal of Cancer · 2023

DOI: 10.1002/ijc.34552 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Joshua P Entrop und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Hodgkin Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Åke Wiberg Stiftelse, Cancerfonden, Kræftens Bekæmpelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Childbirth rates in classical Hodgkin lymphoma (cHL) survivors have historically been reduced compared to the general population. Understanding if contemporary treatment protocols are associated with reduced fertility is crucial as treatment guidelines shift toward more liberal use of intensive chemotherapy. We identified 2834 individuals aged 18‐40 years with cHL in Swedish and Danish lymphoma registers, and in the clinical database at Oslo University Hospital diagnosed 1995‐2018, who were linked to national medical birth registers. Cox regression adjusted for stage, performance status, year, and age at diagnosis was used to estimate hazard ratios (HRs) and 95% confidence intervals (CI) contrasting time to first childbirth by treatment groups (ABVD, 2‐4 BEACOPP, 6‐8 BEACOPP) up to 10 years after diagnosis. Overall, 74.8% of patients were treated with ABVD, 3.1% with 2‐4 BEACOPP and 11.2% with 6‐8 BEACOPP. Adjusted HRs comparing childbirth rates in individuals treated with 6‐8 BEACOPP, and 2‐4 BEACOPP to ABVD were 0.53 (CI: 0.36‐0.77) and 0.33 (CI: 0.12‐0.91) for males, and 0.91 (CI: 0.61‐1.34) and 0.38 (CI: 0.12‐1.21) for females. Cumulative incidence of childbirths after 10 years was 19.8% (CI: 14.5%‐27.0%) for males and 34.3% (CI: 25.8%‐45.6%) for females treated with 6‐8 BEACOPP. Proportions of children born after assisted reproductive technique (ART) treatments were 77.4% (CI: 60.2‐88.6%) for males following 6‐8 BEACOPP, and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseFemaleChildHumansMaleDoxorubicinBleomycinSwedenAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesVinblastineDacarbazineVincristineCyclophosphamideEtoposideReproductionPrednisoneDenmark

Stichwörter der Autor:innen

Hodgkin diseasechemotherapyfertilitylate effects of cancer treatmentsurvivorship

Substanzen

DoxorubicinBleomycinVinblastineDacarbazineVincristineCyclophosphamideEtoposidePrednisone

Autor:innen und Institutionen

  • Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Mathematical Science, Aalborg University, Aalborg, Denmark.
  • Department of Immunology, Genetics and Pathology, Unit of Experimental and Clinical Oncology, Uppsala University, Uppsala, Sweden.
  • Department of Reproductive Medicine, Division of Gynecology and Reproduction, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Joshua P Entrop, Caroline E Weibull, Andreas K Øvlisen, Ingrid Glimelius, Anna Marklund, Harald Holte, Alexander Fosså, Knut B Smeland, Tarec C El-Galaly, Sandra Eloranta

Förderung

  • Åke Wiberg Stiftelse
  • Cancerfonden
  • Kræftens Bekæmpelse

Zitieren

APA

Entrop, J. P., Weibull, C. E., Smedby, K. E., Jakobsen, L. H., Øvlisen, A. K., Molin, D., Glimelius, I., Marklund, A., Holte, H., Fosså, A., Smeland, K. B., El-Galaly, T. C., & Eloranta, S. (2023). Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study. International Journal of Cancer. https://doi.org/10.1002/ijc.34552

Vancouver

Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, Øvlisen AK, Molin D, et al. Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study. International Journal of Cancer. 2023. doi:10.1002/ijc.34552

BibTeX
@article{Entrop2023,
  author = {Entrop, Joshua P and Weibull, Caroline E and Smedby, Karin E and Jakobsen, Lasse H and Øvlisen, Andreas K and Molin, Daniel and Glimelius, Ingrid and Marklund, Anna and Holte, Harald and Fosså, Alexander and Smeland, Knut B and El-Galaly, Tarec C and Eloranta, Sandra},
  title = {Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study},
  journal = {International Journal of Cancer},
  year = {2023},
  doi = {10.1002/ijc.34552}
}
Kostenlos starten →